BenevolentAI’s CEO Joerg Moeller is stepping down effective immediately, the London biotech said Thursday, in the latest leadership shakeup atop the company.
Since going public …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter
Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a phase 3 study, potentially clearing the way for regulatory approval,
California stands on the cusp of a psychedelic revolution with the TREAT Act and a landmark bill on ‘magic mushrooms,’ even as Michigan, Congress, and